Header Logo

Stephen Korbet

Concepts (346)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney
23
2023
152
3.730
Why?
Kidney Diseases
15
2014
71
2.570
Why?
Glomerulosclerosis, Focal Segmental
21
2012
32
2.300
Why?
Lupus Nephritis
16
2019
27
2.130
Why?
Peritoneal Dialysis
17
2011
26
1.770
Why?
Biopsy, Needle
9
2021
103
1.770
Why?
Kidney Failure, Chronic
22
2012
127
1.290
Why?
Biopsy
14
2018
200
1.170
Why?
Nephrology
4
2018
11
1.140
Why?
Proteinuria
12
2019
50
1.130
Why?
Prognosis
25
2023
801
1.120
Why?
Glomerulonephritis
12
2007
13
1.100
Why?
Peritoneal Dialysis, Continuous Ambulatory
12
2002
13
1.100
Why?
Kidney Glomerulus
19
2023
39
1.070
Why?
Humans
111
2023
27185
0.960
Why?
Glomerulonephritis, IGA
3
2023
7
0.950
Why?
Adult
69
2021
7886
0.930
Why?
Creatinine
13
2019
41
0.800
Why?
Peritonitis
7
2002
17
0.770
Why?
Renal Dialysis
9
2012
82
0.760
Why?
Nephrosis, Lipoid
5
2019
11
0.760
Why?
Needles
2
2021
19
0.760
Why?
Male
64
2021
14834
0.750
Why?
Middle Aged
50
2021
9011
0.740
Why?
Hematuria
6
2014
15
0.730
Why?
Acute Kidney Injury
4
2019
37
0.710
Why?
Steroids
6
2012
23
0.700
Why?
Female
66
2021
15271
0.680
Why?
Nephrotic Syndrome
8
2019
23
0.650
Why?
Immunosuppressive Agents
8
2023
120
0.620
Why?
Nephrologists
1
2018
3
0.620
Why?
Radiologists
1
2018
8
0.610
Why?
Scleroderma, Limited
1
2018
3
0.610
Why?
Renal Insufficiency, Chronic
2
2019
44
0.610
Why?
Practice Patterns, Physicians'
1
2018
110
0.560
Why?
Prospective Studies
10
2021
1777
0.530
Why?
Clinical Competence
2
2018
210
0.510
Why?
Cystatin C
1
2015
3
0.480
Why?
Automation
1
2014
10
0.470
Why?
Image-Guided Biopsy
1
2014
37
0.460
Why?
Education, Medical, Continuing
1
2014
33
0.430
Why?
Plasmapheresis
6
2013
13
0.380
Why?
Eosinophilia
3
2011
39
0.370
Why?
Renal Insufficiency
3
2006
13
0.370
Why?
Dermatitis, Allergic Contact
1
2011
5
0.370
Why?
Pruritus
1
2011
10
0.370
Why?
Severity of Illness Index
7
2019
891
0.370
Why?
Time Factors
7
2018
1442
0.370
Why?
Silicones
1
2011
11
0.360
Why?
Catheters, Indwelling
1
2011
23
0.360
Why?
Follow-Up Studies
13
2014
1801
0.360
Why?
Internship and Residency
2
2014
216
0.350
Why?
Prednisone
10
2019
66
0.350
Why?
Reproducibility of Results
5
2021
680
0.340
Why?
Glomerular Filtration Rate
5
2015
39
0.340
Why?
Lupus Erythematosus, Systemic
6
1999
189
0.340
Why?
Retrospective Studies
19
2023
3561
0.330
Why?
Aged
25
2021
9053
0.320
Why?
Remission Induction
6
2013
90
0.310
Why?
Peritoneum
6
2000
16
0.310
Why?
Recurrence
6
2019
313
0.310
Why?
Anemia
4
1995
33
0.300
Why?
Amyloid Neuropathies, Familial
1
2008
3
0.290
Why?
Ultrasonography, Interventional
3
2018
69
0.290
Why?
Survival Rate
9
2013
344
0.290
Why?
Bacterial Infections
2
2000
51
0.290
Why?
Equipment Design
2
2021
139
0.290
Why?
AIDS-Associated Nephropathy
4
2011
7
0.280
Why?
Adolescent
10
2014
2194
0.260
Why?
Multiple Myeloma
1
2006
19
0.260
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2003
18
0.260
Why?
Anti-Inflammatory Agents
4
2019
77
0.250
Why?
Erythropoietin
4
1995
7
0.250
Why?
Cyclosporins
2
1998
3
0.240
Why?
Hemorrhage
4
2009
85
0.230
Why?
Kidney Transplantation
4
1994
118
0.230
Why?
Hematoma
3
2009
19
0.230
Why?
Young Adult
7
2014
2014
0.210
Why?
Methylprednisolone
1
2003
19
0.210
Why?
Renal Replacement Therapy
2
2019
18
0.200
Why?
Ultrasonography
3
2014
225
0.200
Why?
Aged, 80 and over
11
2014
4817
0.200
Why?
Nephrosis
3
2004
3
0.200
Why?
Multivariate Analysis
5
2019
332
0.190
Why?
Urban Population
2
2000
153
0.190
Why?
Hypertension
4
2018
194
0.190
Why?
Risk Factors
11
2011
2324
0.190
Why?
Ethylene Glycol
1
2001
3
0.180
Why?
Antidotes
1
2001
4
0.180
Why?
Mycoses
1
2000
20
0.170
Why?
Polycystic Kidney Diseases
1
2000
4
0.170
Why?
von Hippel-Lindau Disease
1
2000
5
0.170
Why?
Pyrazoles
1
2001
61
0.170
Why?
Survival Analysis
6
2007
260
0.170
Why?
Child
9
2009
1298
0.160
Why?
Neoplasms, Multiple Primary
1
2000
40
0.160
Why?
Carcinoma, Renal Cell
1
2000
47
0.160
Why?
Dialysis Solutions
2
1998
4
0.160
Why?
Kidney Neoplasms
1
2000
79
0.160
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
1998
110
0.160
Why?
Immune Complex Diseases
2
1992
2
0.160
Why?
Amlodipine
1
2018
3
0.150
Why?
Lisinopril
1
2018
3
0.150
Why?
Labetalol
1
2018
4
0.150
Why?
Nicardipine
1
2018
4
0.150
Why?
Fellowships and Scholarships
1
2018
37
0.150
Why?
Prevalence
4
2003
453
0.150
Why?
Antihypertensive Agents
1
2018
54
0.150
Why?
Vasculitis
3
2005
26
0.150
Why?
Hemofiltration
2
1995
7
0.140
Why?
Lung Diseases
2
2005
45
0.140
Why?
Glycation End Products, Advanced
2
1994
7
0.140
Why?
Treatment Outcome
10
2010
3536
0.140
Why?
Urban Health
2
1995
22
0.130
Why?
Logistic Models
2
2014
398
0.130
Why?
Drug Resistance
2
2012
47
0.130
Why?
Liver Transplantation
2
1995
92
0.130
Why?
Biomarkers
1
2019
558
0.130
Why?
Liver Failure
1
1995
10
0.120
Why?
Glomerulonephritis, Membranoproliferative
2
1996
2
0.120
Why?
Disease Progression
4
2011
670
0.110
Why?
Actin Cytoskeleton
1
1994
6
0.110
Why?
Pregnancy Complications
2
2005
49
0.110
Why?
Ultrafiltration
3
2000
4
0.110
Why?
Blood Pressure Determination
1
1994
14
0.110
Why?
Thrombosis
2
1993
56
0.110
Why?
Peritoneal Diseases
2
1998
4
0.110
Why?
Immunoglobulin G
2
2009
79
0.100
Why?
Hematocrit
2
1995
15
0.100
Why?
Phosphorus
1
2012
7
0.100
Why?
Ferric Compounds
1
2012
4
0.100
Why?
Chelating Agents
1
2012
13
0.100
Why?
Blood Pressure
1
1994
195
0.100
Why?
Diabetes Mellitus
1
1993
129
0.100
Why?
Polymorphism, Single Nucleotide
3
2008
277
0.100
Why?
Apolipoproteins
1
2011
6
0.090
Why?
Lipoproteins, HDL
1
2011
23
0.090
Why?
Patch Tests
1
2011
2
0.090
Why?
Renal Artery Obstruction
1
1991
3
0.090
Why?
Exanthema
1
2011
12
0.090
Why?
Anti-Glomerular Basement Membrane Disease
1
1989
1
0.080
Why?
Endocarditis, Bacterial
1
1989
11
0.080
Why?
Case-Control Studies
4
2011
590
0.080
Why?
Amyloidosis
2
2006
20
0.080
Why?
Antibodies, Antineutrophil Cytoplasmic
2
2009
7
0.080
Why?
Diet
1
2010
217
0.080
Why?
Molecular Motor Proteins
1
2008
1
0.080
Why?
Chromosomes, Human, Pair 22
1
2008
10
0.080
Why?
Mutation
2
2007
350
0.080
Why?
Hypertension, Renal
2
2002
3
0.080
Why?
Myosin Heavy Chains
1
2008
8
0.080
Why?
Treatment Failure
2
2002
160
0.080
Why?
Hemolysis
1
2008
5
0.080
Why?
Haplotypes
1
2008
58
0.080
Why?
Poisson Distribution
2
2000
21
0.070
Why?
Heart Valve Prosthesis
1
2008
12
0.070
Why?
Mitral Valve
1
2008
9
0.070
Why?
Aortic Valve
1
2008
24
0.070
Why?
Vascular Diseases
1
2008
42
0.070
Why?
Age Factors
3
2019
774
0.070
Why?
Lipoproteins
1
2007
10
0.070
Why?
Apolipoprotein E2
1
2007
12
0.070
Why?
Mutation, Missense
1
2007
25
0.070
Why?
Glomerulonephritis, Membranous
3
2001
3
0.070
Why?
Intracellular Signaling Peptides and Proteins
1
2007
54
0.070
Why?
Genotype
4
2011
353
0.070
Why?
Patient Compliance
2
2000
149
0.070
Why?
Nursing Homes
1
2007
36
0.070
Why?
Skilled Nursing Facilities
1
2007
31
0.070
Why?
Genetic Predisposition to Disease
1
2008
380
0.070
Why?
Membrane Proteins
1
2007
169
0.070
Why?
Staphylococcus epidermidis
2
1996
4
0.060
Why?
Anemia, Pernicious
1
1986
1
0.060
Why?
Autoantibodies
1
2006
80
0.060
Why?
Biological Transport
2
1998
39
0.060
Why?
Immunity, Maternally-Acquired
1
2005
1
0.060
Why?
Pedigree
2
2007
66
0.060
Why?
Isoantibodies
1
2005
7
0.060
Why?
Genes, Wilms Tumor
1
2005
1
0.060
Why?
Population
1
2005
5
0.060
Why?
Diabetes Insipidus
1
1985
2
0.060
Why?
Analysis of Variance
2
1996
258
0.060
Why?
Ambulatory Care
2
1996
69
0.060
Why?
Laryngeal Diseases
1
1984
3
0.060
Why?
Chicago
2
1999
949
0.060
Why?
Blood Transfusion
3
1996
65
0.060
Why?
Coronary Disease
1
1984
51
0.060
Why?
Algorithms
1
2006
352
0.060
Why?
Staphylococcal Infections
2
1996
161
0.060
Why?
Cyclophosphamide
3
2010
49
0.050
Why?
Nephrons
1
2003
6
0.050
Why?
Predictive Value of Tests
3
2019
478
0.050
Why?
Diabetic Nephropathies
2
1994
17
0.050
Why?
Educational Status
2
1995
290
0.050
Why?
Contraindications
1
2002
31
0.050
Why?
Radiography, Interventional
1
2002
16
0.050
Why?
Immunoglobulins
2
1992
13
0.050
Why?
Suicide, Attempted
1
2001
14
0.040
Why?
New York City
1
2000
12
0.040
Why?
Complement C3
3
1990
4
0.040
Why?
Incidence
3
2000
758
0.040
Why?
Urea
2
1996
10
0.040
Why?
Education, Medical, Graduate
1
2000
79
0.040
Why?
Age of Onset
2
2011
95
0.040
Why?
Clinical Trials as Topic
2
2019
216
0.040
Why?
Curriculum
1
2000
140
0.040
Why?
Body Mass Index
1
2002
462
0.040
Why?
Forecasting
2
1996
92
0.040
Why?
Sclerosis
1
1999
69
0.040
Why?
Capillary Action
1
1998
1
0.040
Why?
Lymph
1
1998
1
0.040
Why?
Fluid Shifts
1
1998
1
0.040
Why?
Glycosylation
1
1998
19
0.040
Why?
Treatment Refusal
1
1998
11
0.040
Why?
Tissue Adhesions
1
1998
10
0.040
Why?
Microtubules
2
1991
28
0.040
Why?
Water
1
1998
30
0.040
Why?
Catheterization
1
1998
41
0.040
Why?
Genetic Variation
2
2011
98
0.040
Why?
Edema
2
1996
25
0.040
Why?
Proportional Hazards Models
1
2019
348
0.040
Why?
Microscopy, Electron
3
2002
63
0.040
Why?
Syndrome
2
2005
77
0.040
Why?
Longitudinal Studies
2
2019
1365
0.030
Why?
Databases, Factual
1
2019
350
0.030
Why?
Diagnosis, Differential
2
2002
351
0.030
Why?
Iron
2
2012
15
0.030
Why?
United States
4
2011
2056
0.030
Why?
Child, Preschool
1
1998
645
0.030
Why?
Ciprofloxacin
1
1995
11
0.030
Why?
Weight Gain
1
1996
64
0.030
Why?
Socioeconomic Factors
1
1996
302
0.030
Why?
Gram-Negative Bacterial Infections
1
1995
23
0.030
Why?
Chi-Square Distribution
1
1995
138
0.030
Why?
Sepsis
1
1996
114
0.030
Why?
Sex Factors
1
1996
467
0.030
Why?
Uremia
1
1994
4
0.030
Why?
Double-Blind Method
2
1995
403
0.030
Why?
Risk Assessment
1
1996
631
0.030
Why?
Hypertrophy
1
1993
24
0.030
Why?
Pregnancy
2
2005
340
0.030
Why?
Canada
3
2000
46
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
1993
90
0.030
Why?
Monitoring, Physiologic
1
1994
71
0.030
Why?
Regression Analysis
1
1994
260
0.030
Why?
Recombinant Proteins
2
1995
183
0.030
Why?
Postoperative Complications
2
1991
927
0.030
Why?
Ferritins
1
2012
4
0.030
Why?
Chronic Kidney Disease-Mineral and Bone Disorder
1
2012
3
0.030
Why?
Color
1
2012
7
0.030
Why?
Constipation
1
2012
17
0.030
Why?
Complement System Proteins
1
1992
8
0.020
Why?
Terminology as Topic
1
1992
32
0.020
Why?
Substance Abuse, Intravenous
1
1992
10
0.020
Why?
Seizures
1
1993
73
0.020
Why?
Feces
1
2012
103
0.020
Why?
Quality of Life
2
1996
632
0.020
Why?
Human Genome Project
1
2011
1
0.020
Why?
HapMap Project
1
2011
1
0.020
Why?
Apolipoprotein L1
1
2011
4
0.020
Why?
Nephritis, Interstitial
2
1995
2
0.020
Why?
Renal Artery
1
1991
8
0.020
Why?
Crystallization
1
1991
4
0.020
Why?
Kaplan-Meier Estimate
1
2011
178
0.020
Why?
Circadian Rhythm
1
1994
230
0.020
Why?
Neoplasms
1
1993
236
0.020
Why?
Graft Rejection
1
1990
69
0.020
Why?
Cryoglobulinemia
1
1989
1
0.020
Why?
Diagnostic Errors
1
1989
28
0.020
Why?
Acute Disease
1
1989
177
0.020
Why?
Hemodynamics
1
1989
63
0.020
Why?
Lod Score
1
2008
20
0.020
Why?
Chromosome Mapping
1
2008
43
0.020
Why?
DNA Primers
1
2008
51
0.020
Why?
Genetic Linkage
1
2008
58
0.020
Why?
Lung
1
1989
169
0.020
Why?
Cohort Studies
2
2009
1894
0.020
Why?
Genome, Human
1
2008
50
0.020
Why?
Remission, Spontaneous
1
1988
8
0.020
Why?
Cardiovascular Diseases
1
1991
322
0.020
Why?
Administration, Oral
1
2007
110
0.020
Why?
Sensitivity and Specificity
1
2009
481
0.020
Why?
Surveys and Questionnaires
1
2012
1155
0.020
Why?
Drug Therapy, Combination
1
2007
169
0.020
Why?
Glucocorticoids
1
2007
68
0.020
Why?
Arteriosclerosis
1
1987
11
0.020
Why?
Diabetes Complications
1
2007
56
0.020
Why?
Multicenter Studies as Topic
2
1996
44
0.020
Why?
Prescriptions
2
1996
17
0.020
Why?
Clinical Protocols
2
1996
58
0.020
Why?
Animals
1
1994
3642
0.020
Why?
Intrinsic Factor
1
1986
1
0.020
Why?
Schilling Test
1
1986
1
0.020
Why?
Antibodies
1
1986
46
0.020
Why?
Hemoglobins
1
1986
33
0.020
Why?
Cryoglobulins
1
1985
1
0.020
Why?
Glomerular Mesangium
1
1985
2
0.020
Why?
Basement Membrane
1
1985
11
0.020
Why?
Maternal-Fetal Exchange
1
2005
6
0.020
Why?
Peroxidase
1
2005
14
0.020
Why?
Microscopy, Fluorescence
1
1985
79
0.020
Why?
Fetal Blood
1
2005
13
0.020
Why?
Denys-Drash Syndrome
1
2005
1
0.010
Why?
Frasier Syndrome
1
2005
1
0.010
Why?
Autoantigens
1
2005
26
0.010
Why?
Kidney Concentrating Ability
1
1985
1
0.010
Why?
Cesarean Section
1
2005
30
0.010
Why?
Pre-Eclampsia
1
1985
7
0.010
Why?
Exons
1
2005
34
0.010
Why?
Vasopressins
1
1985
8
0.010
Why?
Antigen-Antibody Complex
1
2004
4
0.010
Why?
Emergencies
1
2005
32
0.010
Why?
Eosinophils
1
1985
42
0.010
Why?
Capillaries
1
2004
11
0.010
Why?
Dyspnea
1
2005
42
0.010
Why?
Practice Guidelines as Topic
2
1996
260
0.010
Why?
Cyclosporine
1
2004
12
0.010
Why?
Airway Obstruction
1
1984
19
0.010
Why?
Models, Theoretical
1
2005
84
0.010
Why?
Phenotype
1
2005
314
0.010
Why?
Myocardial Infarction
1
1984
133
0.010
Why?
Infant, Newborn
1
2005
584
0.010
Why?
World Health Organization
1
2001
9
0.010
Why?
International Cooperation
1
2000
15
0.010
Why?
Osmotic Pressure
1
2000
5
0.010
Why?
Water-Electrolyte Balance
1
2000
4
0.010
Why?
Demography
1
2000
73
0.010
Why?
Guidelines as Topic
1
2000
57
0.010
Why?
Minority Groups
1
2000
81
0.010
Why?
Body Surface Area
1
1996
3
0.010
Why?
Nutritional Physiological Phenomena
1
1996
5
0.010
Why?
Consensus Development Conferences as Topic
1
1996
6
0.010
Why?
Costs and Cost Analysis
1
1996
32
0.010
Why?
Permeability
1
1996
97
0.010
Why?
Nutritional Status
1
1996
56
0.010
Why?
Leukocyte Count
2
1987
63
0.010
Why?
Social Environment
1
1996
76
0.010
Why?
Necrosis
1
1995
26
0.010
Why?
Injections, Subcutaneous
1
1995
22
0.010
Why?
Life Style
1
1996
186
0.010
Why?
Erythrocyte Transfusion
1
1995
12
0.010
Why?
Epithelium
1
1989
28
0.000
Why?
Complement C4
1
1987
3
0.000
Why?
Antibodies, Antinuclear
1
1987
11
0.000
Why?
Pyuria
1
1985
1
0.000
Why?
Urinary Tract Infections
1
1985
31
0.000
Why?
Korbet's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (346)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_